{"id":"phenallymal","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"alphenal","offLabel":[],"synonyms":["fenallymal","phenallymal","allofenyl","allophenylum","alphenal","alphenate","phenallymalum","prophenal"],"timeline":[],"approvals":[],"brandName":"Alphenal","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells are like locks, and proteins or receptors are like keys. Alphenal is like a key that fits into a specific lock, allowing it to turn and unlock a particular cellular process. This process can help to treat a variety of diseases, but the exact mechanism is still unknown.","oneSentence":"Alphenal works by binding to specific proteins or receptors in the body to produce a therapeutic effect.","technicalDetail":"Alphenal is a small molecule that likely interacts with specific biological targets, such as enzymes, receptors, or ion channels, to produce its therapeutic effect. The exact nature of these interactions is unclear, but they may involve changes in signaling pathways, gene expression, or other cellular processes."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3810","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=phenallymal","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:18:27.068097","biosimilars":[],"competitors":[],"genericName":"phenallymal","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"7T7L08Q9JI","CHEBI":"CHEBI:134993","PUBCHEM_CID":"8274"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Alphenal, also known as phenallymal, is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it has not been approved by the FDA for any indications. As a small molecule, it is likely to work by interacting with specific biological molecules to produce a therapeutic effect. However, without more information, it is difficult to provide a comprehensive summary of its use and safety profile. Further research is needed to determine its potential as a therapeutic agent.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}